Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $4 | $5 |
| % Growth | 3.5% | 18.1% | -5.6% | – |
| Cost of Goods Sold | $4 | $4 | $3 | $4 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 23.3% | 23.4% | 23% | 22% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 7.5% | 7.5% | 6.6% | 6.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.9% | 4.5% | 4.4% | 2.8% |
| EPS | 2.57 | 2.26 | 1.85 | 1.27 |
| % Growth | 13.7% | 22.2% | 45.7% | – |
| EPS Diluted | 2.54 | 2.24 | 1.83 | 1.25 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 13% | 12.6% | 13.1% | 12.1% |